pcr to neoadjuvant treatment with or without atezolizumab in early hr tnbc
Published 4 years ago • 350 plays • Length 11:42Download video MP4
Download video MP3
Similar videos
-
1:27
what to do in patients with early-stage tnbc who have not achieved a pcr?
-
6:54
no pcr in patients after neoadjuvant chemotherapy in tnbc
-
5:28
evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...
-
2:55
impassion031 supports neoadjuvant atezolizumab in early tnbc | nadia harbeck
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
4:20
keynote 522: pembrolizumab as neoadjuvant treatment for early tnbc
-
5:21
optimal neoadjuvant and adjuvant therapy for patients with early tnbc
-
7:36
esmo 2020 expert video report on atezolizumab in upfront treatment of tnbc
-
3:37
tnbc: immunotherapy in the neoadjuvant setting
-
4:49
adding atezolizumab to adjuvant chemotherapy for stage ii and iii triple-negative breast cancer ...
-
1:07
neotrip: efs in neoadjuvant atezolizumab with taxane/carboplatin ± anthracycline in high-risk tnbc
-
2:17
atezolizumab with adjuvant chemotherapy for early-stage triple negative breast cancer
-
20:46
session 10: neoadjuvant and adjuvant treatment of patients with tnbc (javier cortes, spain)
-
13:03
early tnbc - pembrolizumab chemotherapy: pathologic complete response in key subgroups
-
31:24
harnessing the immune system in the treatment of triple-negative breast cancer
-
7:44
prediction of pcr by hrd after carboplatin neoadjuvant chemotherapy in tnbc patients
-
1:42
impassion031: patient-reported outcomes
-
17:21
ctdna detection after neoadjuvant ct significantly associated with disease recurrence in early tnbc
-
5:54
case 3: treatment after progression in triple-negative breast cancer